ArticleJournal of computer-aided molecular design2025
AI-driven molecular modeling and design: from property prediction to drug generation.
Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Integrating the techniques of deep learning, particularly graph neural network models, has made a significant advancement in drug discovery by facilitating effective exploration of chemical spaces and precise prediction of molecular properties. This paper presents a deep learning approach: molecular encoder, property predictor, molecular generator, and realness classifier (ME&PP-MG&RC). which integrates the molecular encoding and property prediction (ME&PP) component and the molecular generation and realness classification (MG&RC) component to help the prediction and discovery of new molecular compounds. Encoding molecular structures in latent space using graph neural network models, our approach allows for accurate prediction of properties such as quantum mechanical properties (HOMO, LUMO, and gap) for QM9 and pharmaceutical properties (QED, LogP, and SAS) for ZINC datasets. ME&PP component achieves the highest performance in property prediction with lower average absolute errors compared to existing methods after evaluation. Additionally, the approach produces molecules that are chemically diverse and valid, and they are checked by a realness classifier to make sure that they are practical. Results demonstrate the potential of ME&PP-MG&RC to revolutionize computational molecular design and drug discovery, providing a unified pipeline for precise property predictions, new molecular generation, and reality validation. This integrated approach represents a major step towards the automation of drug discovery and paves the way for the accelerated identification of innovative therapeutic candidates.
Indexed as
Identifiers
41460590What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.